Search results
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 5 hours agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters via Yahoo News· 3 days ago(Reuters) -AbbVie expects a drop in sales volumes of its blockbuster arthritis drug Humira to deepen...
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 3 days agoAlthough that has meant Humira’s market share dropped from 96% to 81% over two weeks, Stewart said...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 1 day agoEven so, AbbVie expects to return to top-line growth in 2025. Its roster of newer medicines is picking up the slack. That's particularly the case with ...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 3 days ago"This is despite the significant increase in U.S. biosimilar market share in April," Leerink...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 7 days agoFree Report) will announce quarterly earnings of $2.26 per share in its forthcoming report, representing a decline of 8.1% year over year. Ahead of a company's earnings disclosure, it is crucial ...
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 3 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 4 days agoNewer immunology medicines, Skyrizi and Rinvoq, are performing extremely well, bolstered by approval...
AbbVie Lifts Outlook After 1Q Revenue Unexpectedly Rises
Morningstar· 3 days agoBy Dean Seal AbbVie raised its annual adjusted earnings guidance after revenue unexpectedly rose in the first quarter as lower sales of Humira were offset with gains elsewhere. The drugmaker now expects adjusted earnings, which strip out
CPAP Stock Rockets As Quarterly Report Wipes Out Weight-Loss Woes
Investor's Business Daily· 3 days agoResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss...
